Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: STAAR Surgical Company, 3 years.
STAAR Surgical Company
Director
Tarsus Pharmaceuticals Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 16, 2025 | Tarsus Pharmaceuticals Inc. | Open-market sale | −1,006 | $41.08 | $41,326 |
| Jun 13, 2025 | Tarsus Pharmaceuticals Inc. | Option exercise | +3,350 | — | — |
| Jun 24, 2024 | Tarsus Pharmaceuticals Inc. | Option exercise | +3,350 | — | — |
| Jun 20, 2024 | STAAR Surgical Company | Grant or award | +2,244 | — | — |
| Sep 21, 2023 | STAAR Surgical Company | Open-market purchase | +2,500 | $40.00 | $100,000 |
| Aug 15, 2023 | Tarsus Pharmaceuticals Inc. | Open-market purchase | +9,506 | $16.80 | $159,701 |
| Jun 16, 2023 | Tarsus Pharmaceuticals Inc. | Option exercise | +2,000 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.